This prospective European study looks at the response to tocilizumab in corticosteroid-resistant disease. Tocilizumab (TCZ) is a monoclonal antibody that competitively inhibits IL-6 binding to its receptor. Unlike teprotumumab, the advantage of TCZ is that it is already used within...
In the first of the two articles (see Part 2 here) on paediatric cataracts, Samuel Aryee reviews the aetiology of this condition. Cataracts arise from opacification of the natural transparent lens, which can cause partial or total blindness. Although the...
One of the lovely things about clinical meetings and conferences is the ability to meet with your peers and ask questions of them about their practice. Often the questions are not earth shattering, for example, it could be as simple...
The author shares a clinical case from Edinburgh Royal Infirmary’s archives. It is not often in the course of a clinical career that one gets the opportunity to review a patient who had been treated by a pioneer neurosurgeon some...
An action-packed programme at this year’s BCLA Clinical Conference and Exhibition will feature world class speakers delivering the latest innovation and clinical insight alongside live demonstrations and hands-on workshops.
The Association of British Dispensing Opticians (ABDO) is calling on everyone across the optical professions and industry to save 9 October 2023 for the third SEE Summit on the Environment.
Boosting understanding amongst the entire practice team about what happens in the optical lens manufacturing process was a keynote lecture which drew a packed audience to the OSA stand at 100% Optical.
The global eye care professional network’s “unquenchable thirst for learning” ensured the success of the first in-person BCLA Clinical Conference & Exhibition in four years.